A citation-based method for searching scientific literature

Sibel Ertek, Sevki Cetinkalp. Curr Vasc Pharmacol 2014
Times Cited: 6







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
66


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
50

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
50

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
50

Basal insulin and cardiovascular and other outcomes in dysglycemia.
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
33


Effects of a cognitive behavioural treatment in patients with type 2 diabetes when added to managed care; a randomised controlled trial.
Laura M C Welschen, Patricia van Oppen, Sandra D M Bot, Piet J Kostense, Jacqueline M Dekker, Giel Nijpels. J Behav Med 2013
27
33



Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands.
Hata Zavrelova, Trynke Hoekstra, Marjan Alssema, Laura M C Welschen, Giel Nijpels, Annette C Moll, Henrica C W de Vet, Bettine C P Polak, Jacqueline M Dekker. Diabetes Care 2011
37
33


Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.
Craig J Currie, Chris D Poole, Marc Evans, John R Peters, Christopher Ll Morgan. J Clin Endocrinol Metab 2013
134
33



Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
David J Margolis, Ole Hoffstad, Brian L Strom. Pharmacoepidemiol Drug Saf 2008
81
33

The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.
Stanley S Schwartz, Solomon Epstein, Barbara E Corkey, Struan F A Grant, James R Gavin, Richard B Aguilar. Diabetes Care 2016
135
33

A1C and cardiovascular outcomes in type 2 diabetes: a nested case-control study.
Danielle C Colayco, Fang Niu, Jeffrey S McCombs, T Craig Cheetham. Diabetes Care 2011
67
33



Intensive insulin for type 2 diabetes: the risk of causing harm.
Christopher J Nolan, Neil B Ruderman, Marc Prentki. Lancet Diabetes Endocrinol 2013
23
33

Glycemic control in type 2 diabetes: time for an evidence-based about-face?
Victor M Montori, Mercè Fernández-Balsells. Ann Intern Med 2009
124
33

Intensified glucose lowering in type 2 diabetes: time for a reappraisal.
J S Yudkin, B Richter, E A M Gale. Diabetologia 2010
95
33


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
33

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial.
Steven P Marso, Neil R Poulter, Steven E Nissen, Michael A Nauck, Bernard Zinman, Gilbert H Daniels, Stuart Pocock, William M Steinberg, Richard M Bergenstal, Johannes F E Mann,[...]. Am Heart J 2013
144
33


Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda, Ling Ge, Madeline McCarren, William C Duckworth, Nicholas V Emanuele. N Engl J Med 2015
367
33


Insulin use and increased risk of mortality in type 2 diabetes: a cohort study.
J-M Gamble, S H Simpson, D T Eurich, S R Majumdar, J A Johnson. Diabetes Obes Metab 2010
88
33

Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction.
Kevin Noel Keane, Vinicius Fernandes Cruzat, Rodrigo Carlessi, Paulo Ivo Homem de Bittencourt, Philip Newsholme. Oxid Med Cell Longev 2015
163
33

Prospective evaluation of the effect of statins on blood pressure control in hypertensive patients in clinical practice.
M G Prandin, A F G Cicero, A Dormi, M Veronesi, E R Cosentino, C Borghi. Nutr Metab Cardiovasc Dis 2010
10
16

Uric acid metabolism in pre-hypertension and the metabolic syndrome.
Manfredi Rizzo, Milan Obradovic, Milica Labudovic-Borovic, Dragana Nikolic, Giuseppe Montalto, Ali A Rizvi, Dimitri P Mikhailidis, Esma R Isenovic. Curr Vasc Pharmacol 2014
13
16

Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement.
Genovefa D Kolovou, Dimitri P Mikhailidis, Jan Kovar, Dennis Lairon, Børge G Nordestgaard, Teik Chye Ooi, Pablo Perez-Martinez, Helen Bilianou, Katherine Anagnostopoulou, George Panotopoulos. Curr Vasc Pharmacol 2011
227
16

Cut-off points of waist circumference and body mass index for detecting diabetes, hypercholesterolemia and hypertension according to National Non-Communicable Disease Risk Factors Surveillance in Iran.
Abbaszadeh-Ahranjani Shabnam, Kashani Homa, Mohajeri-Tehrani Mohammad Reza, Larijani Bagher, Forouzanfar Mohammad Hossein, Afshani Hamidreza. Arch Med Sci 2012
18
16

The effect of body mass index and fasting glucose on the relationship between blood pressure and incident diabetes mellitus: a 5-year follow-up study.
Won Young Lee, Chang Hee Kwon, Eun Jung Rhee, Jeong Bae Park, Young Kwon Kim, Sook Young Woo, Seonwoo Kim, Ki Chul Sung. Hypertens Res 2011
10
16

Metabolic syndrome and renal disease.
Anna Gluba, Dimitri P Mikhailidis, Gregory Y H Lip, Simon Hannam, Jacek Rysz, Maciej Banach. Int J Cardiol 2013
57
16

Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study.
Arrigo F G Cicero, Sergio D'Addato, Maddalena Veronesi, Martina Rosticci, Francesca Santi, Ada Dormi, Claudio Borghi. J Hypertens 2012
20
16

The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials.
Maciej Banach, Shekoufeh Nikfar, Roja Rahimi, Agata Bielecka-Dabrowa, Michael J Pencina, Dimitri P Mikhailidis, Krzysztof Narkiewicz, Jacek Rysz, Kausik K Ray, Mohammad Abdollahi. Int J Cardiol 2013
31
16

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.
Annie C St-Pierre, Bernard Cantin, Gilles R Dagenais, Pascale Mauriège, Paul-Marie Bernard, Jean-Pierre Després, Benoît Lamarche. Arterioscler Thromb Vasc Biol 2005
293
16

Recommendations for severe hypertriglyceridemia treatment, are there new strategies?
Theodosios D Filippatos, Moses S Elisaf. Curr Vasc Pharmacol 2014
13
16

Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results.
Mariusz Stepien, Kinga Rosniak-Bak, Marek Paradowski, Malgorzata Misztal, Krzysztof Kujawski, Maciej Banach, Jacek Rysz. Med Sci Monit 2011
49
16

Pre-CKD- do we need another hero?
Jolanta Malyszko, Maciej Banach. Curr Vasc Pharmacol 2014
5
20

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.
Vassilios G Athyros, Olga Giouleme, Emmanouel S Ganotakis, Moses Elisaf, Konstantinos Tziomalos, Themistoklis Vassiliadis, Evangelos N Liberopoulos, Eleni Theocharidou, Asterios Karagiannis, Dimitri P Mikhailidis. Arch Med Sci 2011
72
16

Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet?
Stephanie Seneff, Glyn Wainwright, Luca Mascitelli. Arch Med Sci 2011
29
16

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Stephan Lüders, Joachim Schrader, Jürgen Berger, Thomas Unger, Walter Zidek, Michael Böhm, Martin Middeke, Wolfgang Motz, Cornelia Lübcke, Andrea Gansz,[...]. J Hypertens 2008
144
16


CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner.
Mark O Huising, Talitha van der Meulen, Joan M Vaughan, Masahito Matsumoto, Cynthia J Donaldson, Hannah Park, Nils Billestrup, Wylie W Vale. Proc Natl Acad Sci U S A 2010
51
16

Metabolic syndrome: definitions and controversies.
Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas, George Chrousos. BMC Med 2011
583
16

Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study.
Mariusz Stępień, Rafał N Wlazeł, Marek Paradowski, Maciej Banach, Magdalena Rysz, Małgorzata Misztal, Jacek Rysz. Arch Med Sci 2012
51
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.